Related Experiment Video
Updated: Feb 17, 2026
10:37
Transcranial Direct Current Stimulation tDCS for Memory Enhancement
Published on: September 18, 2021
15.9K
Alzheimer disease knowledge among gerontologists in Turkiye
İrem Tanriverdi1, İrem Bilgic1, Ozge Pasin2
1Department of Geriatric Medicine, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkiye.
Gerontology & Geriatrics Education
|February 16, 2026
Summary
Gerontology graduates in Turkiye have moderate Alzheimer's disease (AD) knowledge. Female, employed, and self-perceived knowledgeable graduates scored higher, indicating a need for targeted education in AD caregiving and prevention.
Area of Science:
- Gerontology
- Neuroscience
- Public Health
Background:
- Alzheimer's disease (AD) poses a significant global health challenge.
- Assessing the knowledge of gerontology graduates is crucial for effective AD care.
- Understanding factors influencing AD knowledge can inform educational strategies.
Purpose of the Study:
- To evaluate Alzheimer's disease (AD) knowledge levels among gerontology graduates in Turkiye.
- To identify demographic and professional factors associated with AD knowledge.
- To pinpoint specific areas of strength and weakness in AD understanding.
Main Methods:
- Cross-sectional study involving 100 gerontology graduates in Turkiye.
- Online survey utilizing the Turkish Alzheimer's Disease Knowledge Scale (ADKS-TR) and demographic questions.
- Statistical analysis including Mann-Whitney U and Kruskal-Wallis tests (p < .05 significance).
Main Results:
- Overall moderate AD knowledge (mean ADKS-TR score: 22.04 ± 3.44).
- Higher scores observed in female, employed, and self-perceived knowledgeable graduates.
- Knowledge gaps identified in 'Caregiving,' prevention, and decision-making, despite strong understanding of symptoms and diagnosis.
Conclusions:
- Gerontology graduates in Turkiye exhibit moderate AD knowledge, influenced by gender, employment, and self-perception.
- Significant knowledge deficits in practical aspects of AD caregiving and prevention require attention.
- Continuous, practice-oriented educational programs are essential to enhance professional competence in Alzheimer's disease care.
More Related Videos
Related Concept Videos
01:26Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
01:22Alzheimer's Disease: Treatment
994
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
994
01:30Dementia
584
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
584
01:15Drug Dosing: Geriatric Patients
281
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
281
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
717
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
717
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
242
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
242